Nov 10, 2021 7:00am EST Sutro Biopharma Reports Third Quarter 2021 Financial Results, Business Highlights, and Anticipated 2021 Milestones
Oct 12, 2021 7:00am EDT Sutro Biopharma and BioNova Pharmaceuticals Enter into Collaboration for STRO-001 in Greater China
Sep 30, 2021 7:00am EDT Sutro Biopharma Announces Extension of Cytokine Derivative Research Program Under Collaboration with Merck
Sep 17, 2021 5:00pm EDT Sutro Biopharma Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Sep 01, 2021 7:00am EDT Sutro Biopharma to Participate in the 2021 Wells Fargo Virtual Healthcare Conference
Aug 18, 2021 7:00am EDT Sutro Biopharma Announces STRO-002 FDA Fast Track Designation for Patients with Advanced Ovarian Cancer
